30 September 2009
Research, development and manufacturing company Almac (Northern Ireland) has secured permission for "major expansion plans" that could lead to the creation of over 500 jobs during the next five years. The company has acquired a 5.4 acre site adjacent to its Craigavon headquarters and will shortly embark on the first phase of development there. Last year, its UK staff numbers rose by 15% to 1,426 and US staff by 10% to 762.
Group Chairman Sir Allen McClay said: "This is an exciting time for Almac. Since our foundation in 2001 we have grown at record levels, and we expect this trend to continue over the coming years. With our rapid rate of growth it was important to put proper plans in place and provide the necessary room for Almac to expand."
The company is also presently engaged in construction of its new $112 million North American Headquarters.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.